Marco Verhofstadt
Vorsitzender bei NovioSense BV
Profil
Marco Verhofstadt is currently the Chairman-Supervisory Board at NovioSense BV and also holds a position as Principal at Philips BV.
In the past, he worked as the General Manager-Direct Diabetes at Mediq BV (OLD).
Aktive Positionen von Marco Verhofstadt
Unternehmen | Position | Beginn |
---|---|---|
NovioSense BV
NovioSense BV Medical DistributorsDistribution Services NovioSense BV is a holding company that develops wireless platform technology for the non-invasive monitoring of disease biomarkers. It manufactures an ophthalmic insert that measures glucose levels continuously in tear fluid. The company was founded by Christopher Wilson in 2012 and is headquartered in Nijmegen, the Netherlands. | Vorsitzender | 01.01.2012 |
Philips BV | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Marco Verhofstadt
Unternehmen | Position | Ende |
---|---|---|
Mediq BV (OLD)
Mediq BV (OLD) Medical/Nursing ServicesHealth Services Mediq BV provides pharmaceuticals, medical devices, and related care services. The firm offers continence, infusion therapy, medical nutrition, ostomy, respiratoir, and wound care. The company was founded in 1899 and is headquartered in De Meern, the Netherlands. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Mediq BV (OLD)
Mediq BV (OLD) Medical/Nursing ServicesHealth Services Mediq BV provides pharmaceuticals, medical devices, and related care services. The firm offers continence, infusion therapy, medical nutrition, ostomy, respiratoir, and wound care. The company was founded in 1899 and is headquartered in De Meern, the Netherlands. | Health Services |
Philips BV | |
NovioSense BV
NovioSense BV Medical DistributorsDistribution Services NovioSense BV is a holding company that develops wireless platform technology for the non-invasive monitoring of disease biomarkers. It manufactures an ophthalmic insert that measures glucose levels continuously in tear fluid. The company was founded by Christopher Wilson in 2012 and is headquartered in Nijmegen, the Netherlands. | Distribution Services |